
|Slideshows|December 26, 2017
Statins and Risk of Parkinson Disease
Author(s)Veronica Hackethal, MD
There has been long-running controversy regarding the association between statins and PD risk. Two studies with conflicting results are examined here.
Advertisement
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Understanding VTX3232’s Effects on Patients with Early-Stage Parkinson Disease
2
FDA Accepts New Drug Application for Tau PET Imaging Agent MK-6240 in Alzheimer Disease
3
Exenatide Alters Motor Network Activity in Parkinson Disease, Though Clinical Impact Remains Limited
4
Ocrelizumab’s Encouraging Treatment Effects Across Conception Delivery and Breastfeeding
5








































